(Q46879540)

English

Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study

scientific article published in December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

hepatorenal syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jean-Marie Péron

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

Christophe Bureau

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

Laurent Gonzalez

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

Franck Garcia-Ricard

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

Olivier de Soyres

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

Emmanuel Dupuis

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

Laurent Alric

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

Jacques Pourrat

8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

Jean-Pierre Vinel

9

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

language of work or name

0 references

publication date

1 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

100

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

12

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

2702-2707

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

Hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Terlipressin-induced vasoconstriction reversed with N-acetylcysteine: a case for combined use in hepatorenal syndrome?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Renal prostacyclin influences renal function in non-azotemic cirrhotic patients treated with furosemide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Assessment of intrathoracic blood volume as an indicator of cardiac preload: single transpulmonary thermodilution technique versus assessment of pressure preload parameters derived from a pulmonary artery catheter

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00271.X

21 January 2018

Identifiers

10.1111/J.1572-0241.2005.00271.X

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16393223

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46879540&oldid=2135614801"